50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,620.09 (-2.66%)
DOW   29,070.39 (-2.07%)
QQQ   269.25 (-3.82%)
AAPL   140.98 (-5.91%)
MSFT   234.77 (-2.61%)
META   136.12 (-3.88%)
GOOGL   96.09 (-3.96%)
AMZN   113.33 (-3.97%)
TSLA   267.15 (-7.18%)
NVDA   119.82 (-5.92%)
NIO   15.42 (-11.02%)
BABA   78.00 (-3.69%)
AMD   63.23 (-7.50%)
T   15.43 (-2.53%)
MU   49.30 (-3.33%)
CGC   2.79 (-8.22%)
F   11.42 (-6.24%)
GE   62.00 (-3.82%)
DIS   96.39 (-3.03%)
AMC   6.93 (-9.65%)
PYPL   88.01 (-3.41%)
PFE   44.04 (-0.88%)
NFLX   236.25 (-3.65%)
S&P 500   3,620.09 (-2.66%)
DOW   29,070.39 (-2.07%)
QQQ   269.25 (-3.82%)
AAPL   140.98 (-5.91%)
MSFT   234.77 (-2.61%)
META   136.12 (-3.88%)
GOOGL   96.09 (-3.96%)
AMZN   113.33 (-3.97%)
TSLA   267.15 (-7.18%)
NVDA   119.82 (-5.92%)
NIO   15.42 (-11.02%)
BABA   78.00 (-3.69%)
AMD   63.23 (-7.50%)
T   15.43 (-2.53%)
MU   49.30 (-3.33%)
CGC   2.79 (-8.22%)
F   11.42 (-6.24%)
GE   62.00 (-3.82%)
DIS   96.39 (-3.03%)
AMC   6.93 (-9.65%)
PYPL   88.01 (-3.41%)
PFE   44.04 (-0.88%)
NFLX   236.25 (-3.65%)
S&P 500   3,620.09 (-2.66%)
DOW   29,070.39 (-2.07%)
QQQ   269.25 (-3.82%)
AAPL   140.98 (-5.91%)
MSFT   234.77 (-2.61%)
META   136.12 (-3.88%)
GOOGL   96.09 (-3.96%)
AMZN   113.33 (-3.97%)
TSLA   267.15 (-7.18%)
NVDA   119.82 (-5.92%)
NIO   15.42 (-11.02%)
BABA   78.00 (-3.69%)
AMD   63.23 (-7.50%)
T   15.43 (-2.53%)
MU   49.30 (-3.33%)
CGC   2.79 (-8.22%)
F   11.42 (-6.24%)
GE   62.00 (-3.82%)
DIS   96.39 (-3.03%)
AMC   6.93 (-9.65%)
PYPL   88.01 (-3.41%)
PFE   44.04 (-0.88%)
NFLX   236.25 (-3.65%)
S&P 500   3,620.09 (-2.66%)
DOW   29,070.39 (-2.07%)
QQQ   269.25 (-3.82%)
AAPL   140.98 (-5.91%)
MSFT   234.77 (-2.61%)
META   136.12 (-3.88%)
GOOGL   96.09 (-3.96%)
AMZN   113.33 (-3.97%)
TSLA   267.15 (-7.18%)
NVDA   119.82 (-5.92%)
NIO   15.42 (-11.02%)
BABA   78.00 (-3.69%)
AMD   63.23 (-7.50%)
T   15.43 (-2.53%)
MU   49.30 (-3.33%)
CGC   2.79 (-8.22%)
F   11.42 (-6.24%)
GE   62.00 (-3.82%)
DIS   96.39 (-3.03%)
AMC   6.93 (-9.65%)
PYPL   88.01 (-3.41%)
PFE   44.04 (-0.88%)
NFLX   236.25 (-3.65%)
NASDAQ:TLRY

Tilray - TLRY Stock Forecast, Price & News

$2.87
-0.14 (-4.65%)
(As of 09/29/2022 02:15 PM ET)
Add
Compare
Today's Range
$2.82
$3.01
50-Day Range
$2.70
$4.30
52-Week Range
$2.65
$13.95
Volume
586,836 shs
Average Volume
16.72 million shs
Market Capitalization
$1.54 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.78

Tilray MarketRank™ Forecast

Analyst Rating
Hold
2.08 Rating Score
Upside/​Downside
134.6% Upside
$6.78 Price Target
Short Interest
Healthy
12.03% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.71mentions of Tilray in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$2.21 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.22) to ($0.16) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.01 out of 5 stars

Consumer Staples Sector

94th out of 145 stocks

Medicinals & Botanicals Industry

9th out of 15 stocks

TLRY stock logo

About Tilray (NASDAQ:TLRY) Stock

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.

Receive TLRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tilray and its competitors with MarketBeat's FREE daily newsletter.

TLRY Stock News Headlines

Tilray (NASDAQ:TLRY) Shares Up 3.7%
1 Reason Tilray's Management Promises Could Go Up in Smoke
3 Stocks to Buy for 1,000% Gains - InvestorPlace
RIFF Cannabis Brand Launches 'Drumsticks' - GlobeNewswire
Why Tilray Brands Stock Rose Today
See More Headlines
Receive TLRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tilray and its competitors with MarketBeat's FREE daily newsletter.

TLRY Company Calendar

Last Earnings
7/28/2022
Today
9/29/2022
Next Earnings (Confirmed)
10/07/2022
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:TLRY
Fax
N/A
Employees
1,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.78
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+136.3%
Consensus Rating
Hold
Rating Score (0-4)
2.08
Research Coverage
12 Analysts

Profitability

Net Income
$-476,800,000.00
Pretax Margin
-70.13%

Debt

Sales & Book Value

Annual Sales
$628.37 million
Book Value
$8.34 per share

Miscellaneous

Free Float
519,387,000
Market Cap
$1.54 billion
Optionable
Optionable
Beta
2.51

Key Executives

  • Mr. Edward Wood Pastorius Jr. (Age 50)
    Chief Revenue Officer
  • Mr. Brendan  KennedyMr. Brendan Kennedy (Age 46)
    Pres, CEO & Director
  • Mr. Mark Castaneda (Age 53)
    CFO, Sec. & Treasurer
  • Dr. Catherine Jacobson
    Director of Clinical Research & Member of Medical Advisory Board













TLRY Stock - Frequently Asked Questions

Should I buy or sell Tilray stock right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last twelve months. There are currently 2 sell ratings, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TLRY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLRY, but not buy additional shares or sell existing shares.
View TLRY analyst ratings
or view top-rated stocks.

What is Tilray's stock price forecast for 2022?

12 Wall Street analysts have issued 1 year price objectives for Tilray's shares. Their TLRY share price forecasts range from $3.00 to $12.00. On average, they expect the company's share price to reach $6.78 in the next year. This suggests a possible upside of 125.3% from the stock's current price.
View analysts price targets for TLRY
or view top-rated stocks among Wall Street analysts.

How have TLRY shares performed in 2022?

Tilray's stock was trading at $7.03 at the start of the year. Since then, TLRY shares have decreased by 57.2% and is now trading at $3.01.
View the best growth stocks for 2022 here
.

When is Tilray's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, October 7th 2022.
View our TLRY earnings forecast
.

How can I listen to Tilray's earnings call?

Tilray will be holding an earnings conference call on Friday, October 7th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Tilray's earnings last quarter?

Tilray Inc (NASDAQ:TLRY) issued its quarterly earnings data on Thursday, July, 28th. The company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.27. The firm had revenue of $153.30 million for the quarter, compared to analyst estimates of $151.53 million. Tilray had a negative net margin of 71.52% and a negative trailing twelve-month return on equity of 4.14%. The business's revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the company posted ($0.11) EPS.

What is Brendan Kennedy's approval rating as Tilray's CEO?

32 employees have rated Tilray Chief Executive Officer Brendan Kennedy on Glassdoor.com. Brendan Kennedy has an approval rating of 51% among the company's employees. This puts Brendan Kennedy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tilray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Block (SQ).

When did Tilray IPO?

(TLRY) raised $135 million in an initial public offering on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company served as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

What is Tilray's stock symbol?

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

How do I buy shares of Tilray?

Shares of TLRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tilray's stock price today?

One share of TLRY stock can currently be purchased for approximately $3.01.

How much money does Tilray make?

Tilray (NASDAQ:TLRY) has a market capitalization of $1.61 billion and generates $628.37 million in revenue each year. The company earns $-476,800,000.00 in net income (profit) each year or ($0.89) on an earnings per share basis.

How many employees does Tilray have?

The company employs 1,800 workers across the globe.

How can I contact Tilray?

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The official website for the company is www.tilray.com. The company can be reached via phone at 206-432-9325.

This page (NASDAQ:TLRY) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.